A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Furosemide in Healthy Male and Female Adults
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2011
At a glance
- Drugs Sucroferric oxyhydroxide (Primary) ; Furosemide
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- 29 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 29 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2011 New trial record